Lutein, zeaxanthin and mammalian development: Metabolism, functions and implications for health

https://doi.org/10.1016/j.abb.2018.04.008Get rights and content

Highlights

  • Lutein and zeaxanthin play an important role in visual and cognitive development.

  • Maternal blood and milk provide lutein and zeaxanthin to the growing fetus/infant.

  • Mechanisms of maternal-fetal transfer and milk incorporation are still unknown.

  • Lutein and zeaxanthin status should be monitored in newborns and lactating mothers.

Abstract

It is now widely accepted that nutrition during critical periods in early development, both pre- and postnatal, may have lifetime consequences in determining health or onset of major diseases in the adult life. Dietary carotenoids have shown beneficial health effects throughout the life cycle due to their potential antioxidant properties, their ability to serves as precursors of vitamin A and to the emerging signaling functions of their metabolites. The non-provitamin A carotenoids lutein and zeaxanthin are emerging as important modulators of infant and child visual and cognitive development, as well as critical effectors in the prevention and treatment of morbidity associated with premature births. This review provides a general overview of lutein and zeaxanthin metabolism in mammalian tissues and highlights the major advancements and remaining gaps in knowledge in regards to their metabolism and health effects during pre- and early post-natal development. Furthering our knowledge in this area of research will impact dietary recommendation and supplementation strategies aimed at sustaining proper fetal and infant growth.

Introduction

In mammals, including humans, pre- and early post-natal development heavily depends on nutrients provided by the mother through the placenta (pre-birth) and during lactation (after-birth) [[1], [2], [3], [4]]. Carotenoids are examples of such nutrients that can be detected in the maternal circulation and milk [5]. Carotenoids are C40 isoprenoid compounds synthesized by plants, algae, and bacteria. In plants, they support photosynthesis, function as precursors of various hormones, and enable critical functions, such as pollination and seed dispersion, by providing the characteristic yellow, red and orange color to many fruits and flowers [[6], [7], [8]]. Mammals obtain dietary carotenoids predominantly through foods of plant origin. Even though hundreds of carotenoids exist in nature, only about 50 of them are commonly present in the human diet, and only about 10 of these can be detected in significant amounts in the human plasma. Examples include β-carotene, α-carotene, β-cryptoxanthin, lycopene, lutein, zeaxanthin, and β-canthaxanthin [9]. Dietary carotenoids have shown beneficial health effects throughout the life cycle due to their potential antioxidant properties, their ability to serves as precursors of vitamin A and to the emerging signaling functions of their metabolites [[10], [11], [12]]. Of note, evidence for their potential harmful activities also exists [[13], [14], [15], [16]]. The majority of the literature on the biological functions of carotenoids centers on their actions in adult tissues and organs. This review will focus on carotenoid metabolism and functions during pre- and early post-natal development. The most well-known contribution of these compounds to mammalian development is linked to the provitamin A activity of certain carotenoids, specifically β-carotene [17]. The essential nutrient vitamin A indeed supports proper mammalian development by exerting critical transcriptional regulatory activities mediated by its active form retinoic acid [18,19]. The emphasis of this review, however, will be on the role of the non-provitamin A carotenoids lutein and zeaxanthin. These carotenoids, which are not only transferred from mother to fetus through the placenta, but are also abundant in the mother's milk [5], are emerging as important modulators of infant and child visual and cognitive development, as well as critical effectors in the prevention and treatment of morbidity associated with premature births [5]. We will provide a general overview of lutein and zeaxanthin metabolism in mammalian tissue. We will also highlight the major advancements and remaining gaps in knowledge in regards to their metabolism and health effects during pre- and early post-natal development.

Section snippets

Chemical structure, food sources and bioavailability

Based on their chemical structure, carotenoids can be classified as carotenes and xanthophylls. Carotenes (such as β-carotene, α-carotene, lycopene and β-cryptoxanthin) are non-oxycarotenoids that may be linear or possess cyclic hydrocarbons at one or both ends of the molecule. Xanthophylls (such as lutein, zeaxanthin, meso-zeaxanthin, astaxanthin and canthaxanthin) are oxygen-containing carotenoids [20]. Lutein and zeaxanthin are also characterized by the presence of a hydroxyl group at both

Intestinal absorption and transport

In contrast to the intestinal uptake of β-carotene that has been shown to be mediated by the receptor SR-BI [38,39], the details of the molecular mechanisms of lutein and zeaxanthin uptake by the enterocytes are still scarce [40,41]. It is generally assumed that, like other carotenoids, upon intestinal absorption lutein and zeaxanthin are incorporated in chylomicrons, together with other dietary lipids. Chylomicrons are rapidly remodeled by lipoprotein lipase in peripheral tissues and then

Tissue uptake

The specific affinity of these xanthophylls to the HDL may control their post-hepatic tissue distribution via a preferential tissue uptake mediated by the receptor for HDL-lipoproteins and others key players involved in cholesterol and/or lipid transport. In humans, the highest levels of these pigments are reached in the macula of the eye where their concentrations range between 0.1 and 1 mM [27,45,46]. Confirming earlier studies indicating that xanthophylls are preferentially taken up by

Metabolism

Another possible explanation for the selective accumulation of the xanthophylls in the macula of humans and primates is linked to the metabolism of these carotenoids in tissues. In mammals, two enzymes - β-carotene-15,15′-oxygenase (BCO1) and β-carotene-9′,10′-oxygenase (BCO2) - are responsible for mediating the cleavage of carotenoids at specific sites of the polyene chain [53]. These two enzymes have different substrate specificity for various carotenoids, different cellular localization and

Lutein, zeaxanthin and pre-natal development

Evidence that lutein and zeaxanthin may play a role in pre-natal life comes from the presence of these carotenoids in the cord blood. Lutein is the most abundant carotenoid in cord plasma and its concentration was strongly correlated with maternal plasma lutein, suggesting a possible role in the neonatal period [64]. In normal pregnancy, plasma levels of lutein/zeaxanthin are stable during the first trimester of gestation (0.46–0.48 μmol/L), increase steadily until the third semester

Lutein, zeaxanthin and early post-natal development

Human milk is the only source of nutrients for the newborn thus enabling his/her optimal growth and development. Moreover, milk is the only dietary source of lutein and zeaxanthin before solid food is introduced [84]. A 9-country survey conducted on breast milk carotenoid composition among 471 women determined that levels of lutein plus zeaxanthin in milk were ∼0.043 μmol/L, but individual country means varied from a low of ∼0.043 μmol/L in the U.S. to a high of ∼0.077 μmol/L in Japan [85]. In

Summary and conclusions

A wide-range of investigations have explored the health effects of lutein and zeaxanthin in the past decades. The majority of the studies focused on the functions of these xanthophylls on visual, neural, and cognitive health and often attributed their beneficial effects to their antioxidant and anti-inflammatory properties [21,82,102]. A still limited but growing body of evidence has recently supported the role of lutein and zeaxanthin also in mammalian development, specifically in relationship

Acknowledgments

The work form the author's laboratory presented in this review was supported by grants R01HD057493, R01HD057493-02S1 and R01HD083331 from the U.S. National Institute of Health (NIH) and by NRI award #2006-35200-16580 from USDA-CSREES, Bioactive Food Component for Optimal Health (31.0).

References (115)

  • J.A. Mares-Perlman et al.

    The body of evidence to support a protective role for lutein and zeaxanthin in delaying chronic disease. Overview

    J. Nutr.

    (2002)
  • A. Perry et al.

    Xanthophyll (lutein, zeaxanthin) content in fruits, vegetables and corn and egg products

    J. Food Compos. Anal.

    (2009)
  • H.-Y. Chung et al.

    Lutein bioavailability is higher from lutein-enriched eggs than from supplements and spinach in men

    J. Nutr.

    (2004)
  • P.S. Bernstein et al.

    Lutein, zeaxanthin, and meso-zeaxanthin: the basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease

    Prog. Retin. Eye Res.

    (2016)
  • T. Maoka et al.

    The first isolation of enantiomeric and meso-zeaxanthin in nature

    Comp. Biochem. Physiol. B

    (1986)
  • W. Stahl et al.

    Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humans

    J. Nutr.

    (1992)
  • O.F. O'Connell et al.

    Xanthophyll carotenoids are more bioaccessible from fruits than dark green vegetables

    Nutr. Res.

    (2007)
  • M.S. Micozzi et al.

    Plasma carotenoid response to chronic intake of selected foods and beta-carotene supplements in men

    Am. J. Clin. Nutr.

    (1992)
  • A. During et al.

    Carotenoid transport is decreased and expression of the lipid transporters SR-BI, NPC1L1, and ABCA1 is downregulated in Caco-2 cells treated with ezetimibe

    J. Nutr.

    (2005)
  • P. Borel et al.

    Human plasma levels of vitamin E and carotenoids are associated with genetic polymorphisms in genes involved in lipid metabolism

    J. Nutr.

    (2007)
  • W. Wang et al.

    Effect of dietary lutein and zeaxanthin on plasma carotenoids and their transport in lipoproteins in age-related macular degeneration

    Am. J. Clin. Nutr.

    (2007)
  • B.A. Clevidence et al.

    Association of carotenoids with human plasma lipoproteins

    Methods Enzymol.

    (1993)
  • O. Ziouzenkova et al.

    Lack of correlation between the alpha-tocopherol content of plasma and LDL, but high correlations for gamma-tocopherol and carotenoids

    J. Lipid Res.

    (1996)
  • R.A. Bone et al.

    Distribution of lutein and zeaxanthin stereoisomers in the human retina

    Exp. Eye Res.

    (1997)
  • R.A. Bone et al.

    Lutein and zeaxanthin in the eyes, serum and diet of human subjects

    Exp. Eye Res.

    (2000)
  • A. During et al.

    Xanthophylls are preferentially taken up compared with β-carotene by retinal cells via a SRBI-dependent mechanism

    J. Lipid Res.

    (2008)
  • R. Shyam et al.

    All three human scavenger receptor class B proteins can bind and transport all three macular xanthophyll carotenoids

    Arch. Biochem. Biophys.

    (2017)
  • C.B. Kallen et al.

    Steroidogenic acute regulatory protein (StAR) is a sterol transfer protein

    J. Biol. Chem.

    (1998)
  • J. Von Lintig

    Provitamin A metabolism and functions in mammalian biology

    Am. J. Clin. Nutr.

    (2012)
  • C. dela Seña et al.

    Substrate specificity of purified recombinant chicken β-carotene 9′, 10′-oxygenase (BCO2)

    J. Biol. Chem.

    (2016)
  • D. Babino et al.

    Characterization of the role of β-carotene 9, 10-dioxygenase in macular pigment metabolism

    J. Biol. Chem.

    (2015)
  • I.V. Ermakov et al.

    Optical detection methods for carotenoids in human skin

    Arch. Biochem. Biophys.

    (2015)
  • B.K. Costabile et al.

    β-Apo-10′-carotenoids modulate placental microsomal triglyceride transfer protein expression and function to optimize transport of intact β-carotene to the embryo

    J. Biol. Chem.

    (2016)
  • L. Wassef et al.

    β-carotene supplementation decreases placental transcription of LDL receptor-related protein 1 in wild-type mice and stimulates placental β-carotene uptake in marginally vitamin a-deficient mice

    J. Nutr.

    (2012)
  • L. Wassef et al.

    High preformed vitamin a intake during pregnancy prevents embryonic accumulation of intact β-carotene from the maternal circulation in mice

    J. Nutr.

    (2015)
  • G.J. McKay et al.

    Investigation of genetic variation in scavenger receptor class B, member 1 (SCARB1) and association with serum carotenoids

    Ophthalmology

    (2013)
  • I.G. Panova et al.

    Lutein and its oxidized forms in eye structures throughout prenatal human development

    Exp. Eye Res.

    (2017)
  • C.P. Gossage et al.

    Carotenoid composition of human milk during the first month postpartum and the response to β-carotene supplementation

    Am. J. Clin. Nutr.

    (2002)
  • C.L. Sherry et al.

    Lutein supplementation increases breast milk and plasma lutein concentrations in lactating women and infant plasma concentrations but does not affect other carotenoids

    J. Nutr.

    (2014)
  • E.J. Johnson

    A possible role for lutein and zeaxanthin in cognitive function in the elderly

    Am. J. Clin. Nutr.

    (2012)
  • A.J. Roodenburg et al.

    Amount of fat in the diet affects bioavailability of lutein esters but not of α-carotene, β-carotene, and vitamin E in humans

    Am. J. Clin. Nutr.

    (2000)
  • M.A. Zielińska et al.

    Health effects of carotenoids during pregnancy and lactation

    Nutrients

    (2017)
  • H. Hashimoto et al.

    Carotenoids and photosynthesis

    Subcell. Biochem.

    (2016)
  • E. Grotewold

    The genetics and biochemistry of floral pigments

    Annu. Rev. Plant Biol.

    (2006)
  • J.C.M. Beltran et al.

    Apocarotenoids: a new carotenoid-derived pathway

    Subcell. Biochem.

    (2016)
  • J. Von Lintig

    Colors with functions: elucidating the biochemical and molecular basis of carotenoid metabolism

    Annu. Rev. Nutr.

    (2010)
  • V. Shete et al.

    Mammalian metabolism of β-carotene: gaps in knowledge

    Nutrients

    (2013)
  • A.A.O. Xavier et al.

    Carotenoids as a source of antioxidants in the diet

    Subcell. Biochem.

    (2016)
  • G.W. Burton et al.

    Beta-carotene: an unusual type of lipid antioxidant

    Science

    (1984)
  • M. Clagett-Dame et al.

    Vitamin A in reproduction and development

    Nutrients

    (2011)
  • Cited by (0)

    View full text